Your browser is no longer supported. Please, upgrade your browser.
Settings
VCYT Veracyte, Inc. daily Stock Chart
VCYT [NASD]
Veracyte, Inc.
Index- P/E- EPS (ttm)-0.94 Insider Own0.30% Shs Outstand35.40M Perf Week16.28%
Market Cap265.50M Forward P/E- EPS next Y-0.68 Insider Trans0.00% Shs Float33.82M Perf Month21.95%
Income-32.00M PEG- EPS next Q-0.27 Inst Own90.70% Short Float2.40% Perf Quarter25.84%
Sales75.60M P/S3.51 EPS this Y16.00% Inst Trans0.56% Short Ratio7.01 Perf Half Y14.50%
Book/sh0.88 P/B8.52 EPS next Y32.70% ROA-39.70% Target Price9.75 Perf Year-6.02%
Cash/sh0.77 P/C9.76 EPS next 5Y- ROE-81.00% 52W Range5.23 - 9.80 Perf YTD14.85%
Dividend- P/FCF- EPS past 5Y-0.30% ROI-42.50% 52W High-23.47% Beta1.74
Dividend %- Quick Ratio3.60 Sales past 5Y44.00% Gross Margin60.60% 52W Low43.40% ATR0.34
Employees246 Current Ratio4.00 Sales Q/Q22.00% Oper. Margin-37.10% RSI (14)71.76 Volatility6.79% 5.07%
OptionableYes Debt/Eq0.84 EPS Q/Q-10.20% Profit Margin-42.30% Rel Volume0.58 Prev Close7.73
ShortableYes LT Debt/Eq0.84 EarningsMay 01 AMC Payout- Avg Volume115.71K Price7.50
Recom1.80 SMA2015.89% SMA5023.30% SMA2008.13% Volume67,309 Change-2.98%
Nov-07-17Downgrade Piper Jaffray Overweight → Neutral
Nov-07-17Downgrade Janney Buy → Neutral
Aug-31-17Resumed BTIG Research Buy $13
Nov-14-16Resumed Leerink Partners Outperform $12
Dec-18-15Initiated Cantor Fitzgerald Buy $13
Jun-11-15Reiterated Leerink Partners Outperform $11 → $13
Nov-26-13Initiated William Blair Outperform
May-23-18 11:22AM  Veracyte Announces New Study Published in JAMA Surgery Demonstrates Afirma GSCs Ability to Significantly Reduce Unnecessary Surgeries in Thyroid Cancer Diagnosis Business Wire +6.61%
May-19-18 10:00AM  Veracyte Announces That Data From Multiple Studies Demonstrate Real-World Value of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis Business Wire
May-17-18 08:30AM  Veracyte Launches Early Access Program for Envisia Genomic Classifier to Improve Diagnosis of IPF Business Wire
May-16-18 03:19PM  Veracyte Announces Launch of New Afirma Xpression Atlas at 2018 AACE Congress Business Wire
May-10-18 08:10AM  Veracyte to Launch New Afirma Xpression Atlas and Present Platform Performance Data at AACE 2018 Meeting Business Wire
May-09-18 05:22PM  **UPDATED WITH NEW TIME**: Veracyte to Present at the 2018 UBS Global Healthcare Conference Business Wire
08:10AM  Veracyte to Present at the 2018 UBS Global Healthcare Conference Business Wire
04:39AM  Edited Transcript of VCYT earnings conference call or presentation 1-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-01-18 06:03PM  Veracyte: 1Q Earnings Snapshot Associated Press
04:05PM  Veracyte Announces First Quarter 2018 Financial Results Business Wire
08:00AM  Research Report Identifies Altair Engineering, Safety Insurance Group, Tyler Technologies, Veracyte, Enviva Partners, LP, and ABIOMED with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-17-18 04:05PM  Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2018 Financial Results on Tuesday, May 1, 2018 Business Wire
Apr-11-18 08:10AM  Veracyte Announces Precision Medicine Collaboration With Loxo Oncology Business Wire
Mar-19-18 04:10PM  Veracyte Unveils Afirma Xpression Atlas Platform at ENDO 2018 Business Wire
08:15AM  Veracyte Announces New Data Suggesting Afirma GSCs Ability to Help Significantly More Patients Avoid Unnecessary Thyroid Surgery Business Wire
Mar-14-18 08:10AM  Veracyte Announces New Data Demonstrating Real-World Performance of Afirma GSC To Be Presented at ENDO 2018 Business Wire
Mar-02-18 08:20AM  New Research Coverage Highlights Eleven Biotherapeutics, Enova International, Veracyte, Ameris, Veritiv, and United Fire Group Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Feb-28-18 06:05PM  Edited Transcript of VCYT earnings conference call or presentation 27-Feb-18 9:30pm GMT Thomson Reuters StreetEvents
Feb-27-18 07:41PM  Veracyte reports 4Q loss Associated Press
04:00PM  Veracyte Announces Fourth Quarter and Full-Year 2017 Financial Results, Provides 2018 Financial Outlook Business Wire
12:48PM  Veracyte Q4 Earnings Preview Benzinga
12:40PM  Veracyte Inc to Host Earnings Call ACCESSWIRE
Feb-12-18 08:00AM  Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2017 Financial Results on Tuesday, February 27, 2018 Business Wire
Jan-31-18 08:00AM  Veracyte to Present at LEERINK Partners 7th Annual Global Healthcare Conference Business Wire
Jan-25-18 01:54PM  Veracyte Announces 100,000th Afirma Test Performed to Reduce Unnecessary Surgeries in Thyroid Cancer Diagnosis Business Wire
Jan-19-18 11:43AM  Veracytes Chief Science and Medical Officer to Present at The Precision Medicine World Conference Business Wire
Jan-18-18 08:00AM  Veracyte Announces Publication of Results from Patient Survey Quantifying the Challenges in Diagnosing Interstitial Lung Disease Business Wire
Jan-08-18 08:00AM  Report: Exploring Fundamental Drivers Behind United Fire Group, Almost Family, Spark Therapeutics, Veracyte, Ruth's Hospitality Group, and IDT New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
07:30AM  Veracyte Announces Strategic Realignment and New Appointments to Advance Commercial Growth Business Wire
Dec-14-17 09:12AM  Are Options Traders Betting on a Big Move in Veracyte (VCYT) Stock? Zacks
Dec-11-17 02:14PM  ETFs with exposure to Veracyte, Inc. : December 11, 2017 Capital Cube
Dec-01-17 10:49AM  ETFs with exposure to Veracyte, Inc. : December 1, 2017 Capital Cube
Nov-30-17 09:30AM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q3, 2017 By the Numbers : November 30, 2017 Capital Cube
Nov-28-17 08:30AM  Veracyte Announces Publication of Data Confirming Analytical Validity of Envisia Genomic Classifier for Use in IPF Diagnosis Business Wire
Nov-15-17 10:00AM  Veracyte to Present at the Piper Jaffray 29th Annual Healthcare Conference Business Wire
Nov-09-17 05:00PM  Veracyte Announces New Clinical Utility Data Suggesting Envisia Genomic Classifier Enables as Confident a Diagnosis in IPF as Surgical Pathology Business Wire
Nov-06-17 11:31PM  Edited Transcript of VCYT earnings conference call or presentation 6-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
05:07PM  Veracyte reports 3Q loss Associated Press
04:05PM  Veracyte Announces Third Quarter 2017 Financial Results Business Wire
Nov-03-17 04:00PM  CORRECTING and REPLACING Veracyte Announces Presentation of New Clinical Utility Data at CHEST 2017 Showing Percepta Classifier Reduces Invasive Procedures in Lung Cancer Diagnosis Business Wire
Nov-02-17 10:00AM  Veracyte to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum Business Wire
Nov-01-17 08:50AM  Veracyte Announces Presentation of New Clinical Utility Data at CHEST 2017 Showing Percepta Classifier Reduces Invasive Procedures in Lung Cancer Diagnosis Business Wire
Oct-26-17 10:00AM  Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results on Monday, November 6, 2017 Business Wire
Oct-21-17 06:40PM  Veracyte Announces New Data Highlighting Performance of the Afirma GSC Ensemble Machine Learning Algorithms in Challenging Thyroid Cancer Subtypes to Be Presented at ATA Business Wire
Oct-20-17 10:00AM  Veracyte Announces Presentation of New Data Validating Accuracy of BRAF V600E and Parathyroid Tissue Classifiers at ATA Annual Meeting Business Wire
Oct-19-17 08:30AM  Veracyte Announces New Data Demonstrating Clinical Utility of Percepta Bronchial Genomic Classifier to be Presented at CHEST Annual Meeting 2017 Business Wire
Oct-13-17 10:02AM  Veracyte Chairman and CEO Bonnie Anderson Receives Prestigious Innovation Award at Biomedical Engineering Society Annual Meeting Business Wire
Oct-05-17 08:30AM  Veracyte Announces Data From Five Studies Validating the Next-Generation Afirma Genomic Sequencing Classifier to Be Presented at ATA 2017 Annual Meeting Business Wire
Sep-25-17 08:00AM  Veracyte Announces Release of 2018 Preliminary Reimbursement Rate for Afirma Genomic Classifier Under PAMA Business Wire
Sep-19-17 08:03AM  Awareness Campaign Takes Lung Cancer Risk Head-On, Asking North Carolinians To Screen Together PR Newswire
08:00AM  Veracyte Launches Campaign to Save Lives through Early Screening for Lung Cancer Business Wire
Sep-18-17 10:07AM  5 MedTech Stocks to Pick for Stellar Returns Zacks
Sep-13-17 10:00AM  Veracyte to Present at the Cantor Fitzgerald Global Healthcare Conference Business Wire
Sep-11-17 09:31AM  5 Top-Ranked MedTech Growth Stocks for Solid Returns Zacks
Aug-24-17 10:00AM  Veracyte to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Business Wire
Aug-17-17 04:06PM  ETFs with exposure to Veracyte, Inc. : August 17, 2017 Capital Cube
Aug-12-17 07:30PM  Edited Transcript of VCYT earnings conference call or presentation 31-Jul-17 8:30pm GMT Thomson Reuters StreetEvents
04:41AM  Edited Transcript of VCYT earnings conference call or presentation 3-May-17 8:30pm GMT Thomson Reuters StreetEvents
01:00AM  Edited Transcript of VCYT earnings conference call or presentation 1-Mar-17 9:30pm GMT Thomson Reuters StreetEvents
Aug-02-17 03:36PM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q2, 2017 By the Numbers : August 2, 2017 Capital Cube
Jul-31-17 09:17PM  Veracyte reports 2Q loss Associated Press
04:05PM  Veracyte Announces Second Quarter 2017 Financial Results Business Wire
11:00AM  Investor Network: Veracyte Inc. to Host Earnings Call ACCESSWIRE
08:30AM  Veracyte Announces Pivotal Clinical Validation Data for Afirma Genomic Sequencing Classifier Presented at World Congress on Thyroid Cancer Business Wire
Jul-26-17 08:35AM  Veracyte Announces Positive Data From Three Afirma Studies to Be Presented at World Congress on Thyroid Cancer Business Wire
Jun-27-17 08:05AM  Veracyte Announces Publication of Study Supporting the Development of Envisia Genomic Classifier for IPF in Annals of the American Thoracic Society PR Newswire
Jun-26-17 08:00AM  Veracyte Named a San Francisco Bay Area "Top Workplace" For Fourth Consecutive Year PR Newswire
Jun-01-17 01:00PM  Veracyte to Present at William Blair 2017 Growth Stock Conference PR Newswire
May-23-17 03:00PM  Veracyte Announces Clinical Validation Data Demonstrating Envisia Genomic Classifier's Performance in Improving Idiopathic Pulmonary Fibrosis Diagnosis Presented at ATS 2017 PR Newswire
May-18-17 12:18PM  Veracyte Announces Anthem Coverage for the Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis PR Newswire +5.58%
May-11-17 08:30AM  Data Demonstrating Cost-Effectiveness of Veracyte's Percepta® Bronchial Genomic Classifier Published in "Journal of Thoracic Oncology" PR Newswire
May-10-17 08:00AM  Veracyte Announces Six Studies Highlighting Value of Company's Genomic Classifiers in Lung Cancer and Idiopathic Pulmonary Fibrosis To Be Presented at ATS 2017 PR Newswire
May-09-17 05:10PM  ETFs with exposure to Veracyte, Inc. : May 9, 2017 Capital Cube
May-08-17 11:11AM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q1, 2017 By the Numbers : May 8, 2017 Capital Cube -7.18%
08:00AM  Data Presented at AACE 2017 Annual Meeting Demonstrate Long-Term Clinical Utility Of Veracyte's Afirma® Gene Expression Classifier in Thyroid Cancer Diagnosis PR Newswire
May-04-17 04:05PM  Veracyte Announces Pivotal Clinical Validation Data for Next-Generation Afirma® Test To Help More Patients Avoid Unnecessary Surgery in Thyroid Cancer Diagnosis PR Newswire +5.49%
May-03-17 06:11PM  Veracyte reports 1Q loss Associated Press -5.66%
04:05PM  Veracyte Announces First Quarter 2017 Financial Results PR Newswire
Apr-26-17 08:00AM  Veracyte Announces Multiple Studies Demonstrating Powerful Results from Afirma® Classifiers To Be Presented at the AACE 2017 Annual Meeting PR Newswire +5.48%
Apr-19-17 04:30PM  Veracyte to Host Conference Call and Webcast to Discuss First Quarter 2017 Financial Results on Wednesday, May 3, 2017 PR Newswire
Apr-03-17 12:00PM  Multiple Studies Presented at ENDO 2017 Support Use of Veracyte's Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis PR Newswire
Mar-23-17 08:00AM  Veracyte Announces that Multiple Studies Supporting Clinical Utility of Its Afirma® Gene Expression Classifier To Be Presented at ENDO 2017 PR Newswire
Mar-08-17 12:04PM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 8, 2017 Capital Cube
12:04PM  Veracyte, Inc. :VCYT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 8, 2017
Mar-07-17 01:04PM  VERACYTE, INC. Financials
Mar-06-17 04:21PM  VERACYTE, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Mar-01-17 04:56PM  Veracyte reports 4Q loss Associated Press
04:29PM  VERACYTE, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook PR Newswire
07:07AM  Q4 2016 Veracyte Inc Earnings Release - After Market Close
Feb-28-17 04:05PM  Veracyte Announces Executive Promotions PR Newswire
Feb-27-17 10:20AM  Veracyte Announces Publication of Data Demonstrating Potential for Non-Invasive Nasal Test to Improve Lung Cancer Diagnosis PR Newswire
Feb-21-17 08:00AM  Veracyte Announces Ten New Blues Plan Coverage Policies for Its Afirma® Gene Expression Classifier for Use in Thyroid Cancer Diagnosis PR Newswire
Feb-15-17 08:00AM  Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2016 Financial Results on Wednesday, March 1, 2017 PR Newswire
Feb-09-17 09:44AM  Quest Diagnostics Partners with Veracyte for Cancer Testing
Feb-08-17 08:00AM  Veracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics PR Newswire
Feb-06-17 08:00AM  Veracyte Announces Final Medicare Coverage Policies for Percepta® Bronchial Genomic Classifier PR Newswire
Feb-02-17 08:00AM  Veracyte to Present at LEERINK Partners 6th Annual Global Healthcare Conference PR Newswire
Dec-22-16 02:20PM  ETFs with exposure to Veracyte, Inc. : December 22, 2016
Dec-15-16 08:45AM  4 Growth Stocks to Buy Amid Obamacare Repeal Talks
Veracyte, Inc. operates as a genomic diagnostics company in the United States. The company uses genomic technology to resolve diagnostic uncertainty. It offers Afirma Thyroid FNA Analysis solution; cytopathology testing services; and the Afirma Malignancy Classifiers to manage thyroid nodule patients. The company's products also include Percepta Bronchial Genomic Classifier solution for use in lung cancer screening and diagnosis; and Envisia Genomic Classifier solution for idiopathic pulmonary fibrosis. Veracyte, Inc. sells its products through product specialists, institutional managers, account managers, and medical science specialists. Veracyte, Inc. has research collaboration agreement with Loxo Oncology to develop medicines for patients with genetically defined cancers. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Anderson Bonnie HChairman and CEONov 08Option Exercise1.5912,54119,99822,541Nov 09 05:57 PM
Anderson Bonnie HChairman and CEOOct 20Option Exercise2.6810,00026,80020,000Oct 20 04:46 PM
Anderson Bonnie HChairman and CEOOct 20Sale9.6010,00096,00010,000Oct 20 04:46 PM
Anderson Bonnie HChairman and CEOOct 18Option Exercise2.366,00014,16016,000Oct 20 04:46 PM
Anderson Bonnie HChairman and CEOOct 18Sale9.096,00054,55610,000Oct 20 04:46 PM
Hall Christopher MPresident and COOOct 02Option Exercise0.8020,00016,00040,000Oct 04 05:14 PM
Hall Christopher MPresident and COOOct 02Sale9.0020,000180,00020,000Oct 04 05:14 PM
Anderson Bonnie HChairman and CEOSep 25Option Exercise2.366,00014,16016,000Sep 27 04:53 PM
Anderson Bonnie HChairman and CEOSep 25Sale8.446,00050,62410,000Sep 27 04:53 PM
JONES EVAN/ FADirectorAug 28Sale7.842,50019,600279,653Aug 29 04:07 PM
JONES EVAN/ FADirectorAug 25Sale7.8120,000156,200282,153Aug 29 04:07 PM
JONES EVAN/ FADirectorAug 24Sale7.8320,000156,600302,153Aug 25 04:16 PM
JONES EVAN/ FADirectorAug 23Sale7.9220,000158,400322,153Aug 25 04:16 PM